Arrowhead Pharmaceuticals Inc (ARWR)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total assets	US$ in thousands	626,286	765,552	795,856	891,308	891,489	691,939	751,782	703,575	638,539	710,148	734,927	756,795	499,251	522,504	555,728	561,076	587,602	349,845	336,828	333,940
Debt-to-assets ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $626,286K
= 0.00

Based on the data provided for Arrowhead Pharmaceuticals Inc., the debt-to-assets ratio has consistently been reported as 0.00 across all quarters from Q2 2022 to Q1 2024. A debt-to-assets ratio of 0.00 indicates that the company has no financial leverage or debt relative to its total assets during the specified periods.

This consistent ratio suggests that Arrowhead Pharmaceuticals Inc. has been operating with a debt-free capital structure, relying solely on equity financing to support its operations, investments, and growth. A debt-to-assets ratio of 0.00 can be interpreted as a positive sign, indicating a low financial risk and an absence of interest expenses associated with debt repayment.

It is essential to note that while a low or zero debt-to-assets ratio can be favorable in terms of financial stability and risk management, it may also indicate a missed opportunity to leverage debt for potential growth or investment opportunities. Strategic use of debt financing can enhance returns for shareholders, but it also comes with risks that need to be carefully managed.

Overall, based on the consistent 0.00 debt-to-assets ratio for Arrowhead Pharmaceuticals Inc., the company appears to follow a conservative financial strategy of maintaining a debt-free balance sheet, which may appeal to investors seeking lower risk investment opportunities.